Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Limited was incorporated in 1996 and it is a manufacturer of a diverse portfolio of structure Directing Agents, Phase Transfer Catalysts, electrolyte salts for batteries, and Pharmaceutical and Agrochemical Intermediates and other Speciality chemicals[1]
- Market Cap ₹ 2,898 Cr.
- Current Price ₹ 1,238
- High / Low ₹ 1,888 / 1,061
- Stock P/E 70.2
- Book Value ₹ 311
- Dividend Yield 0.16 %
- ROCE 8.91 %
- ROE 9.89 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Tax rate seems low
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|
136 | 206 | 263 | 300 | 434 | 424 | 420 | |
113 | 172 | 208 | 234 | 325 | 363 | 351 | |
Operating Profit | 23 | 34 | 55 | 67 | 109 | 61 | 69 |
OPM % | 17% | 17% | 21% | 22% | 25% | 14% | 16% |
1 | 1 | 1 | 5 | 9 | 2 | 0 | |
Interest | 3 | 4 | 4 | 4 | 5 | 9 | 10 |
Depreciation | 3 | 4 | 5 | 7 | 8 | 10 | 22 |
Profit before tax | 19 | 27 | 48 | 61 | 104 | 45 | 38 |
Tax % | 35% | 25% | 21% | 14% | 8% | -2% | |
12 | 21 | 38 | 52 | 96 | 45 | 38 | |
EPS in Rs | 15.30 | 25.56 | 47.03 | 26.02 | 43.25 | 20.52 | 16.75 |
Dividend Payout % | 0% | 0% | 0% | 19% | 5% | 10% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 26% |
3 Years: | 17% |
TTM: | 6% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 32% |
3 Years: | 9% |
TTM: | -10% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -24% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 23% |
3 Years: | 21% |
Last Year: | 10% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|
Equity Capital | 8 | 8 | 8 | 20 | 22 | 22 | 23 |
Reserves | 51 | 72 | 110 | 146 | 451 | 493 | 704 |
56 | 77 | 91 | 90 | 120 | 170 | 61 | |
28 | 31 | 41 | 59 | 65 | 71 | 52 | |
Total Liabilities | 144 | 188 | 249 | 315 | 658 | 756 | 840 |
57 | 67 | 111 | 120 | 160 | 196 | 435 | |
CWIP | 10 | 6 | 5 | 10 | 51 | 231 | 20 |
Investments | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
76 | 115 | 133 | 185 | 447 | 329 | 385 | |
Total Assets | 144 | 188 | 249 | 315 | 658 | 756 | 840 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|
13 | 7 | 25 | 20 | 20 | 28 | |
-30 | -17 | -40 | -21 | -197 | -101 | |
7 | 17 | 10 | -5 | 235 | 38 | |
Net Cash Flow | -10 | 8 | -5 | -6 | 59 | -36 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|
Debtor Days | 77 | 73 | 69 | 110 | 48 | 73 |
Inventory Days | 148 | 114 | 175 | 173 | 319 | 262 |
Days Payable | 127 | 71 | 87 | 114 | 83 | 52 |
Cash Conversion Cycle | 99 | 116 | 157 | 169 | 283 | 283 |
Working Capital Days | 101 | 117 | 104 | 151 | 164 | 171 |
ROCE % | 22% | 28% | 28% | 26% | 9% |
Documents
Announcements
- Compliance Certificate Pursuant To Regulation 7(3) Of The SEBI (LODR) Regulations, 2015, For The Year Ended 31 March 2024. 12 Apr
- Submission Of Certificate Under Regulation 40(9) & (10) Of The SEBI (LODR) Regulations, 2015 For The Year Ended On 31 March 2024 10 Apr
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 5 Apr
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
26 Mar - Of Schedule of Analyst / Institutional Investor Meeting under the SEBI (LODR) Regulations, 2015.
- Closure of Trading Window 26 Mar
Annual reports
Concalls
-
Jan 2024Transcript PPT REC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Jan 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Jul 2022Transcript PPT
-
Apr 2022Transcript PPT
-
Jan 2022Transcript PPT
-
Oct 2021TranscriptPPT
-
Sep 2021TranscriptPPT
Leading Chemical Manufacturer[1]
It is the largest manufacturer of Structure Directing Agents (SDA) for Zeolites in India.